ACTIVATED COAGULATION POTENTIAL AND FACTOR-VIII BYPASSING ACTIVITY (FEIBA) IN PROTHROMBIN COMPLEX PREPARATIONS

被引：0

作者：

SANDER, W

WILMS, K

机构：

[1] BEZIRKSINST BLUTSPENDE & TRANSFUSIONSWESEN ROSTOCK,ROBERT KOCH STR 10,DDR-2500 ROSTOCK,GER DEM REP

[2] BEZIRKSINST BLUTSPENDE & TRANSFUSIONSWESSEN SCHWERIN,SCHWERIN,GER DEM REP

来源：

ZEITSCHRIFT FUR KLINISCHE MEDIZIN-ZKM | 1989年 / 44卷 / 08期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：711 / 713

页数：3

共 50 条

[11] EFFECTS OF LOW-DOSE FACTOR-VIII INHIBITOR BYPASSING ACTIVITY (FEIBA) IN RESISTANT HEMOPHILIA
ZWAHLEN, H
BECK, EA
ACTA HAEMATOLOGICA, 1980, 64 (01) : 12 - 17
[12] FACTOR-VIII INHIBITOR BYPASSING ACTIVITY
ENGLISH, PJ
SHEPPARD, EM
WENSLEY, RT
LANCET, 1976, 2 (7978): : 207 - 208
[13] FAILURE OF FACTOR-VIII INHIBITOR BYPASSING ACTIVITY (FEIBA) TO SECURE HEMOSTASIS IN HEMOPHILIC PATIENTS WITH ANTIBODIES
PARRY, DH
BLOOM, AL
JOURNAL OF CLINICAL PATHOLOGY, 1978, 31 (11) : 1102 - 1105
[14] THROMBOGENICITY OF ANTI-HEMOPHILIAC PREPARATIONS WITH FACTOR-VIII INHIBITOR BYPASSING ACTIVITY
MELEWSKI, DJ
AMBRUS, JL
AMBRUS, CM
TOURBAF, K
THROMBOSIS AND HAEMOSTASIS, 1981, 46 (01) : 335 - 335
[15] THROMBOGENICITY OF ANTI-HEMOPHILIAC PREPARATIONS WITH FACTOR-VIII INHIBITOR BYPASSING ACTIVITY
MELEWSKI, DJ
HUEBSCHMANN, J
TOURBAF, K
AMBRUS, CM
AMBRUS, JL
JOURNAL OF MEDICINE, 1981, 12 (2-3) : 89 - 96
[16] FACTOR-VIII INHIBITOR BY-PASSING ACTIVITY (FEIBA) IN MANAGEMENT OF PATIENTS WITH FACTOR-VIII INHIBITORS
PRESTON, FE
DINSDALE, RCW
SUTCLIFFE, DJ
BARDHAN, G
WYLD, PJ
HAMLYN, JF
THROMBOSIS RESEARCH, 1977, 11 (05) : 643 - 651
[17] CHARACTERIZATION OF THE INVITRO FACTOR-VIII BYPASSING ACTIVITY
ARONSON, DL
BAGLEY, J
THROMBOSIS AND HAEMOSTASIS, 1981, 46 (01) : 218 - 218
[18] APPARENT INTRINSIC PROTHROMBINASE ACTIVITY OF HUMAN FACTOR-X ZYMOGEN - IDENTIFICATION WITH FACTOR-VIII INHIBITOR BYPASSING ACTIVITY (FEIBA)
ESTRY, DW
TISHKOFF, GH
THROMBOSIS RESEARCH, 1984, 36 (06) : 549 - 562
[19] PROTHROMBIN COMPLEX TO TREAT FACTOR-VIII INHIBITION
TISHKOFF, GH
NEW ENGLAND JOURNAL OF MEDICINE, 1975, 292 (14): : 754 - 755
[20] Factor VIII inhibitor bypassing activity (FEIBA) - addressing safety issues
Aledort, L. M.
HAEMOPHILIA, 2008, 14 (01) : 39 - 43

← 1 2 3 4 5 →